Clinical context
Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.
What was studied
This retrospective study evaluated one eye each from 164 White patients with axial length 26.04–29.72 mm after uncomplicated phacoemulsification with AcrySof IQ SN60WF. Refraction was measured at three months. Sixteen methods included K6, PEARL-DGS, Castrop, Eom, VRF CMAL, four Holladay 1 variants, three SRK/T variants, Holladay 2 NLR, Hoffer Q WK2, Haigis WK2 and Barrett True AL. Outcomes were RMSAE and proportions within ±0.25–1.00 D.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
The specific correction mattered more than the choice to adjust or not. Within 26–30 mm, Holladay 1 NLR and SRK/T WK2 matched modern formulas. This does not justify automatic use in extremely long eyes, negative IOLs or other populations. Validate formulas locally, optimize constants and monitor directional shifts.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.
Limitations
The retrospective study lacked external validation and stopped at 29.72 mm. All patients were White and received one IOL; complicated cases, astigmatism above 2 D and acuity below 0.8 were excluded. Power was selected from Barrett UII or SRK/T, creating possible dependence. Many comparisons make rankings unstable. Verify constants, error distribution, outliers, eye selection, refraction masking and formula versions.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.